These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35793188)

  • 1. Capsaicin 8% for Peripheral Neuropathic Pain Treatment: A Retrospective Cohort Study.
    Vieira IF; de Castro AM; Loureiro MDC; Pinto J; Cardoso C; Assuncao JP
    Pain Physician; 2022 Jul; 25(4):E641-E647. PubMed ID: 35793188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
    Goncalves D; Rebelo V; Barbosa P; Gomes A
    Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
    Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
    Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
    Kern KU; Quandel T; Theis S; Schubert T
    Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsaicin 8% Dermal Patch for Neuropathic Pain in a Pain Unit.
    Ausín-Crespo MD; Martín-de Castro E; Roldán-Cuartero J; de la Beldad-Diez ML; Salcedo-Gámez MÁ; Tong H
    Pain Manag Nurs; 2022 Aug; 23(4):452-457. PubMed ID: 35135709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.
    Casale R
    Expert Rev Neurother; 2021 Oct; 21(10):1147-1158. PubMed ID: 34461799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C; Heskamp ML
    Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesive capsaicin 8% patch for improved control of pain caused by chemotherapy-induced peripheral neuropathy in patients with multiple myeloma: A single-centre, seven-case series.
    Moreno-Alonso D; Llorens-Torromé S; Corcoy de Febrer B; Amandi García M; Serrano-Bermúdez G; Trelis-Navarro J; Mayoral-Rojals V; Serrano-Afonso A
    J Oncol Pharm Pract; 2024 Jun; 30(4):752-758. PubMed ID: 38415287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
    Hansson P; Jensen TS; Kvarstein G; Strömberg M
    Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Blair HA
    Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
    Aitken E; McColl G; Kingsmore D
    Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study.
    Zis P; Bernali N; Argira E; Siafaka I; Vadalouka A
    Pain Physician; 2016; 19(7):E1049-53. PubMed ID: 27676676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
    Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
    Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
    Freynhagen R; Argoff C; Eerdekens M; Engelen S; Perrot S
    Pain Med; 2021 Oct; 22(10):2324-2336. PubMed ID: 33871648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
    Lantéri-Minet M; Perrot S
    Curr Med Res Opin; 2019 Mar; 35(3):417-426. PubMed ID: 30550354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
    Giménez-Milà M; Videla S; Navarro MA; Faulí A; Ojeda A; Bogdanovich A; Moreno LA; Hernández-Cera C; Busquets C
    BMC Anesthesiol; 2014; 14():120. PubMed ID: 25580085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.